For oral formulations, cessation 2448 hours prior is standard practice, though your surgeon and anesthesiologist may adjust this window based on your specific procedure and medical history
Vomiting may follow within hours
From a 10mg vial the 7.5mg draw is 150 IU (1.5mL)

You should contact your GP or healthcare provider if: Severe or worsening pain that does not improve with simple analgesia or interferes significantly with daily activities Persistent symptoms lasting more than one to two weeks without improvement Muscle weakness or difficulty performing routine tasks such as climbing stairs or lifting objects Joint swelling, redness, or warmth , which may indicate inflammatory arthritis or infection Fever or signs of infection accompanying body aches, such as chills, sweating, or feeling generally unwell Dark-coloured urine or reduced urine output, which could suggest dehydration or, rarely, rhabdomyolysis (muscle breakdown) Chest pain, shortness of breath, or palpitations , which require urgent assessment to exclude cardiac causes Severe right upper abdominal pain, fever, or yellowing of the skin/eyes , which may indicate gallbladder disease (a recognised risk with GLP-1 receptor agonists and rapid weight loss) [2] New or worsening visual symptoms if you have pre-existing diabetic retinopathy, as rapid improvement in blood glucose can sometimes temporarily worsen retinopathy [2] Seek immediate medical attention (call 999 or attend A&E) if you experience: Severe abdominal pain, particularly if accompanied by persistent vomiting, which may indicate pancreatitisa rare but serious side effect of GLP-1 receptor agonists [2] Signs of severe allergic reaction (anaphylaxis), including difficulty breathing, facial swelling, or widespread rash Symptoms of severe dehydration, such as confusion, dizziness, rapid heartbeat, or inability to keep fluids down Your healthcare provider may wish to review your medication regimen , assess for potential drug interactions, check blood tests (including kidney function, electrolytes, and creatine kinase if muscle breakdown is suspected), and determine whether dose adjustment or alternative treatment is appropriate

They can assess whether semaglutide may indirectly help with your anemia by addressing underlying conditions like obesity, inflammation, or diabetes
Supplementation with high-quality, clinically proven forms like Setria L-Glutathione should be viewed as one vital component of a comprehensive, multi-disciplinary management strategy